Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Early Post-Stroke Spasticity
NCT02321436Phase 4Completed
- Sponsor
- Ipsen
- Start
- Dec 2014
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 4, randomised, double-blind trial in Upper limb spasticity comparing Dysport Group with Placebo Group (2 arms). Primary endpoint: Time Between the Initial Injection and the Appearance of Reinjection Criteria. Started Dec 2014; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT02321436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02321436.